Position Details
Reference Number 18893
Position Title RadioNuclide Therapy Registrar/Fellow (non-accredited) - 2021
Employment Type Fixed Term Full Time
Division Chief Operating Officer
Location Melbourne
Award Classification Award : Doctors In Training - 43 hours
Classification From: HM25 - REGISTRAR YR1
Classification To: HM30 - REGISTRAR YR6
Position Summary

Fellow in Radionuclide Therapy (non-accredited)

Department for Cancer Imaging :  Full time - 12 months Contract commencing 1 February 2021


Outstanding candidates are encouraged to apply for positions now open at Peter MacCallum Cancer Centre – a place where our normal days are extraordinary; as are the people we care for.


Peter Mac is one of a handful of integrated cancer research, education and treatment centres in the world. Each day our team strives to provide the very best in cancer care, even better treatments and potential cancer cures for all people affected by cancer.


Globally, we are facing one of the most pivotal times in the pursuit of cancer cures, and Peter Mac stands at its forefront. Together, we aim to lead a new era of cancer prevention, care and discovery, supported by state-of-the-art facilities at our new home within the Victorian Comprehensive Cancer Centre building.


Your role in our future.


The Department for Cancer Imaging provides a high level service in cancer diagnosis, staging, therapeutic monitoring and research. We perform more than 8000 PET/CT examinations per annum. Our new home features four PET/CT, two multi-slice quantitative SPECT/CT, two CT, 3T MRI, ultrasound, digital mammography with tomosynthesis. We perform many non-FDG studies including F-18, Ga-68, Cu-64, I-124 and Zr-89 radiotracers for both clinical and research purposes including first in-human studies. There is an integrated large nuclear medicine therapy facility for both outpatient and inpatient care including paediatrics and performing over 400 radionuclide therapy treatments per year with Lu-177, Y-90 or I-131 for malignancies including neuroendocrine, prostate, thyroid and lymphoma.


The Fellow will be involved in all aspects of the radionuclide therapy programme including initial evaluation of patients, administration of therapy, follow-up of patients and participation in multi-disciplinary teams. If from a nuclear medicine background, the fellow will also be involved in the clinical PET / nuclear medicine programme. Participation in pre-existing or new research projects for presentation or publication is strongly encouraged.


A medical degree and registration with the Medical Board of Australia are pre-requisites for appointment. The position is most suited to individuals who have completed nuclear medicine training or seek an elective year of advanced training in nuclear medicine, medical oncology or endocrinology.


Peter Mac offers its employees the following benefits:

• Salary Packaging

• Central City Location

• Employee Assistance Program

• Training and Development Program


Enquiries to:

Dr Aravind Ravi Kumar (Aravind.RaviKumar@petermac.org) or Professor Michael Hofman (Michael.Hofman@petermac.org)


Closing Date:  Tuesday 16th June 2020

Selection Criteria Essential: Registration with the Medical Board of Australia
Desirable: Completion of 2-core years of nuclear medicine training, as accredited by JCT or the equivalent, is highly desirable as this will enable further involvement in the PET and nuclear medicine procedures performed within the department.
Desirable: The position may also be suitable as an elective year of training for advanced trainees in endocrinology or medical oncology.
Contact Person Aravind Ravi Kumar
Contact Number 8559 6603
Alternate Contact Person Michael Hofman
Alternate Contact Number 8559 6914
Closing Date 16/06/2020
Position Description
Position Description - Radionuclide Therapy Fellow - 2021.pdf Open
Application Guide PDF IconView Guide